165 related articles for article (PubMed ID: 14599118)
21. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
Vilhardt H; Bie P
Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
[TBL] [Abstract][Full Text] [Related]
22. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
Cunnah D; Ross G; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
[TBL] [Abstract][Full Text] [Related]
23. Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature.
Verrua E; Mantovani G; Ferrante E; Noto A; Sala E; Malchiodi E; Iapichino G; Peccoz PB; Spada A
Hormones (Athens); 2013; 12(1):135-41. PubMed ID: 23624139
[TBL] [Abstract][Full Text] [Related]
24. Management of early postoperative diabetes insipidus with parenteral desmopressin.
Chanson P; Jedynak CP; Czernichow P
Acta Endocrinol (Copenh); 1988 Apr; 117(4):513-6. PubMed ID: 3291526
[TBL] [Abstract][Full Text] [Related]
25. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
Becker DJ; Foley TP
J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
[TBL] [Abstract][Full Text] [Related]
26. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
[TBL] [Abstract][Full Text] [Related]
28. [Case of severe motor and intellectual disabilities presenting with partial central diabetes insipidus triggered by infection].
Serizawa M; Hatakeyama K; Ono C; Kamiya Y; Aihara M; Nakazawa S
No To Hattatsu; 2004 Sep; 36(5):414-8. PubMed ID: 15461031
[TBL] [Abstract][Full Text] [Related]
29. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
Moses AM; Moses LK; Notman DD; Springer J
J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
[TBL] [Abstract][Full Text] [Related]
30. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Rivkees SA; Dunbar N; Wilson TA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):459-69. PubMed ID: 17550208
[TBL] [Abstract][Full Text] [Related]
31. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
32. Central diabetes insipidus in five cats: clinical presentation, diagnosis and oral desmopressin therapy.
Aroch I; Mazaki-Tovi M; Shemesh O; Sarfaty H; Segev G
J Feline Med Surg; 2005 Dec; 7(6):333-9. PubMed ID: 15927500
[TBL] [Abstract][Full Text] [Related]
33. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
Hammer M; Vilhardt H
J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
[TBL] [Abstract][Full Text] [Related]
34. Differing responses of cortisol to oCRF during endonasal and oral treatment with DDAVP.
Carraro A; Giusti M; Porcella E; Sessarego P; Giordano G
Eur J Clin Invest; 1994 Jul; 24(7):459-62. PubMed ID: 7957502
[TBL] [Abstract][Full Text] [Related]
35. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
36. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
37. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
38. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
[TBL] [Abstract][Full Text] [Related]
40. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]